Literature DB >> 27283943

Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Bengt Zöller1, Xinjun Li2, Jan Sundquist2,3, Kristina Sundquist2.   

Abstract

Inherited hypercoagulable states (i.e. thrombophilia) have been suggested to be involved in retinal vascular occlusion but results are divergent. Vascular micronutrition and ischemia have been hypothesised to be involved in the pathogenesis of glaucoma. This nationwide study determines the importance of family history of venous thromboembolism (VTE) as a risk factor for retinal vein occlusion (RVO), retinal artery occlusion (RAO), primary open angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). A total of 6,007,042 Swedish individuals were studied. Data from the Swedish Multigeneration Register for subjects aged 0-78 years old for the period 1997-2010 were linked to the Swedish Hospital Discharge Register and the Hospital Outpatient Register. Main exposure measure was family history of VTE in first-degree relatives (parents and/or siblings). Main outcomes were hazard ratios (HRs) for RVO, RAO, POAG, and PACG. During follow-up 9036 individuals developed RVO, 2137 individuals developed RAO, 29,176 individuals developed POAG and 1498 individuals developed PACG. There was no association between family history of VTE and risk of RVO (HR = 1.04, 95 % CI 0.98-1.10), RAO (HR = 1.00, 95 % CI 0.89-1.13), POAG (HR = 0.96, 95 % CI 0.93-0.99), and PACG (HR = 0.92, 95 % CI 0.80-1.06) in the crude age and sex adjusted model. The results were similar in the fully adjusted model: RVO (HR = 1.04, 95 % CI 0.99-1.11), RAO (HR = 1.01, 95 % CI 0.89-1.13), POAG (HR = 0.97, 95 % CI 0.94-1.00), and PACG (HR = 0.91, 95 % CI 0.79-1.05). Family history of VTE is not a risk factor for RVO, RAO, POAG and PACG. Thus, it is unlikely that strong and common genetic variants associated with VTE are of importance for these disorders.

Entities:  

Keywords:  Epidemiology; Family history; Glaucoma; Retinal occlusion; Venous thromboembolism

Mesh:

Year:  2016        PMID: 27283943     DOI: 10.1007/s11239-016-1387-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  54 in total

1.  The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.

Authors:  J Larsson; A Hillarp
Journal:  Thromb Res       Date:  1999-11-15       Impact factor: 3.944

2.  Activated protein C resistance is a risk factor for central retinal vein occlusion.

Authors:  R Marcucci; L Bertini; A A Liotta; A Rogolino; E Antonucci; I Ilari; G Pepe; D Prisco
Journal:  Ann Ital Med Int       Date:  2000 Jul-Sep

3.  Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease.

Authors:  Y Chen; M R Stanford; G R Wallace; R W Vaughan; E Kondeatis; F Fortune
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  The Swedish Multi-generation Register.

Authors:  Anders Ekbom
Journal:  Methods Mol Biol       Date:  2011

5.  Activated protein C resistance in patients with central retinal vein occlusion.

Authors:  J Larsson; A Sellman; B Bauer
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

Review 6.  Family history of venous thromboembolism as a risk factor and genetic research tool.

Authors:  Bengt Zöller; Xinjun Li; Henrik Ohlsson; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

7.  Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.

Authors:  Thomas Bombeli; Adila Basic; Joerg Fehr
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

8.  A nationwide family study of venous thromboembolism and risk of arterial vascular disease.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Heart       Date:  2016-04-05       Impact factor: 5.994

Review 9.  Guidance for the management of venous thrombosis in unusual sites.

Authors:  Walter Ageno; Jan Beyer-Westendorf; David A Garcia; Alejandro Lazo-Langner; Robert D McBane; Maurizio Paciaroni
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Thrombophilia and retinal vascular occlusion.

Authors:  Charles J Glueck; Robert K Hutchins; Joel Jurantee; Zia Khan; Ping Wang
Journal:  Clin Ophthalmol       Date:  2012-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.